Kerry A. McLaughlin

542 total citations
18 papers, 339 citations indexed

About

Kerry A. McLaughlin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Kerry A. McLaughlin has authored 18 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 9 papers in Genetics and 8 papers in Surgery. Recurrent topics in Kerry A. McLaughlin's work include Diabetes and associated disorders (9 papers), Pancreatic function and diabetes (8 papers) and Diabetes Management and Research (7 papers). Kerry A. McLaughlin is often cited by papers focused on Diabetes and associated disorders (9 papers), Pancreatic function and diabetes (8 papers) and Diabetes Management and Research (7 papers). Kerry A. McLaughlin collaborates with scholars based in United Kingdom, Germany and Australia. Kerry A. McLaughlin's co-authors include Michael R. Christie, Bryan Charleston, C C Richardson, Richard Feltbower, Miriam Windsor, P. Frost, H M Rowley, Alan Gordon, D. A. Graham and M F McLoughlin and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Diabetes.

In The Last Decade

Kerry A. McLaughlin

18 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kerry A. McLaughlin United Kingdom 9 115 103 94 83 80 18 339
Léonor Palmeira Belgium 12 85 0.7× 56 0.5× 63 0.7× 35 0.4× 28 0.3× 22 450
E Terada Japan 7 171 1.5× 119 1.2× 61 0.6× 58 0.7× 90 1.1× 13 342
Chiara De Maddalena Italy 14 132 1.1× 42 0.4× 37 0.4× 104 1.3× 18 0.2× 29 495
R. Emanoil‐Ravier France 14 140 1.2× 201 2.0× 28 0.3× 61 0.7× 24 0.3× 40 713
Alicia I. Cardoso France 10 120 1.0× 109 1.1× 54 0.6× 16 0.2× 40 0.5× 13 409
Yunna Zhang China 10 38 0.3× 37 0.4× 18 0.2× 61 0.7× 18 0.2× 19 332
Seyyed Mehdy Elahi Canada 13 66 0.6× 240 2.3× 30 0.3× 87 1.0× 12 0.1× 34 530
V R Holden United States 16 181 1.6× 53 0.5× 9 0.1× 62 0.7× 21 0.3× 21 537
Sophie Dhorne‐Pollet France 17 97 0.8× 139 1.3× 9 0.1× 84 1.0× 181 2.3× 33 763
Tamir Ellis United States 11 55 0.5× 323 3.1× 59 0.6× 11 0.1× 107 1.3× 15 575

Countries citing papers authored by Kerry A. McLaughlin

Since Specialization
Citations

This map shows the geographic impact of Kerry A. McLaughlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerry A. McLaughlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerry A. McLaughlin more than expected).

Fields of papers citing papers by Kerry A. McLaughlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerry A. McLaughlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerry A. McLaughlin. The network helps show where Kerry A. McLaughlin may publish in the future.

Co-authorship network of co-authors of Kerry A. McLaughlin

This figure shows the co-authorship network connecting the top 25 collaborators of Kerry A. McLaughlin. A scholar is included among the top collaborators of Kerry A. McLaughlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerry A. McLaughlin. Kerry A. McLaughlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
McLaughlin, Kerry A., Sameena Nawaz, Joseph Cutteridge, et al.. (2022). Loss of tetraspanin‐7 expression reduces pancreatic β‐cell exocytosis Ca2+ sensitivity but has limited effect on systemic metabolism. Diabetic Medicine. 39(12). e14984–e14984. 3 indexed citations
2.
McLaughlin, Kerry A., et al.. (2020). Autoimmunity to tetraspanin-7 in type 1 diabetes. Medical Microbiology and Immunology. 209(4). 437–445. 14 indexed citations
3.
Boag, Alisdair M., Michael R. Christie, Kerry A. McLaughlin, et al.. (2018). A longitudinal study of autoantibodies against cytochrome P450 side-chain cleavage enzyme in dogs (Canis lupus familiaris) affected with hypoadrenocorticism (Addison’s disease). Veterinary Immunology and Immunopathology. 202. 41–45. 4 indexed citations
4.
McLaughlin, Kerry A., C C Richardson, Cristina Brigatti, et al.. (2016). Identification of Tetraspanin-7 as a Target of Autoantibodies in Type 1 Diabetes. Diabetes. 65(6). 1690–1698. 80 indexed citations
5.
6.
Boag, Alisdair M., Michael R. Christie, Kerry A. McLaughlin, et al.. (2015). Autoantibodies against Cytochrome P450 Side-Chain Cleavage Enzyme in Dogs (Canis lupus familiaris) Affected with Hypoadrenocorticism (Addison’s Disease). PLoS ONE. 10(11). e0143458–e0143458. 20 indexed citations
7.
McLaughlin, Kerry A., C C Richardson, Ezio Bonifacio, et al.. (2015). Relationships between major epitopes of the IA-2 autoantigen in Type 1 diabetes: Implications for determinant spreading. Clinical Immunology. 160(2). 226–236. 8 indexed citations
8.
9.
McLaughlin, Kerry A., et al.. (2014). HLA-DR4–Associated T and B Cell Responses to Specific Determinants on the IA-2 Autoantigen in Type 1 Diabetes. The Journal of Immunology. 193(9). 4448–4456. 12 indexed citations
10.
Boag, Alisdair M., et al.. (2013). P450 SIDE-CHAIN CLEAVAGE ENZYME AUTOANTIBODIES IN DOGS WITH RECENTLY DIAGNOSED HYPOADRENOCORTICISM. Journal of Veterinary Internal Medicine. 27(3). 690–690. 1 indexed citations
11.
Richardson, C C, James A. Dromey, Kerry A. McLaughlin, et al.. (2013). High frequency of autoantibodies in patients with long duration type 1 diabetes. Diabetologia. 56(11). 2538–2540. 14 indexed citations
12.
Richardson, C C, Kerry A. McLaughlin, Thomas J. Brown, et al.. (2013). Failure to detect anti-idiotypic antibodies in the autoimmune response to IA-2 in Type 1 diabetes. Autoimmunity. 46(6). 375–381. 2 indexed citations
13.
Boag, Alisdair M., et al.. (2013). P450 side-chain cleavage enzyme autoantibodies in canine Addison's disease. Endocrine Abstracts. 1–1. 1 indexed citations
14.
Graham, D. A., P. Frost, Kerry A. McLaughlin, et al.. (2011). A comparative study of marine salmonid alphavirus subtypes 1–6 using an experimental cohabitation challenge model. Journal of Fish Diseases. 34(4). 273–286. 69 indexed citations
15.
McLaughlin, Kerry A., Julian Seago, Lucy Robinson, Charles Kelly, & Bryan Charleston. (2010). Hsp70 enhances presentation of FMDV antigen to bovine CD4+T cells in vitro. Veterinary Research. 41(3). 36–36. 4 indexed citations
16.
McLaughlin, Kerry A., Munir Iqbal, Julian Seago, et al.. (2010). Hsp110-Mediated Enhancement of CD4 + T Cell Responses to the Envelope Glycoprotein of Members of the Family Flaviviridae In Vitro Does Not Occur In Vivo. Clinical and Vaccine Immunology. 18(2). 311–317. 4 indexed citations
17.
Robinson, Lucy, Miriam Windsor, Kerry A. McLaughlin, et al.. (2010). Foot-and-Mouth Disease Virus Exhibits an Altered Tropism in the Presence of Specific Immunoglobulins, Enabling Productive Infection and Killing of Dendritic Cells. Journal of Virology. 85(5). 2212–2223. 26 indexed citations
18.
Juleff, Nicholas, Miriam Windsor, Eric A. Lefèvre, et al.. (2009). Foot-and-Mouth Disease Virus Can Induce a Specific and Rapid CD4+T-Cell-Independent Neutralizing and Isotype Class-Switched Antibody Response in Naive Cattle. Journal of Virology. 83(8). 3626–3636. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Léonor Palmeira Breakdown of academic impact, for papers by E Terada Breakdown of academic impact, for papers by Chiara De Maddalena Breakdown of academic impact, for papers by R. Emanoil‐Ravier Breakdown of academic impact, for papers by Alicia I. Cardoso Breakdown of academic impact, for papers by Yunna Zhang Breakdown of academic impact, for papers by Seyyed Mehdy Elahi Breakdown of academic impact, for papers by V R Holden Breakdown of academic impact, for papers by Sophie Dhorne‐Pollet Breakdown of academic impact, for papers by Tamir Ellis
Rankless by CCL
2026